By the Top Tier Newswire AI Desk · November 12, 2026 at 12:59 PM ET · reviewed against 8 wire stories
IRHYTHM HLDGS INC (IRTC) is up +6.64% in the latest session. Our newswire has captured 8 stories on IRTC across 6 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
iRhythm Holdings (IRTC) shares rose 6.64% to $94.57 on Wednesday. The primary driver of the move was the company's announcement of a $200 million share repurchase program, which it stated it intends to fund using existing cash and operating cash flows.
What Happened
iRhythm Holdings disclosed the approval of the $200 million buyback authorization in an 8-K filing submitted to the SEC on November 12, 2026. The company, a digital health care firm, indicated that the repurchases will be executed through existing cash and cash equivalents as well as operating cash flows. The announcement followed a period of significant price volatility, with the stock having declined 29.7% over the previous eight trading sessions, dropping from $126.17 to $88.68.
In addition to the buyback news, Stephens lowered its price target for the stock to $120 from $160 while maintaining an Overweight rating. Other analysts also adjusted their views during the same period. Truist Securities maintained a Buy rating but lowered its price target to $140. Freedom Capital Markets maintained its Buy rating on the shares.
What The Data Shows
The stock opened at $89.75, representing a 1.2% gap up from the prior close of $88.68. Trading volume reached 0.4 million shares, which is 0.5 times the three-month daily average. The session high was $94.63 at 12:55 PM ET, while the session low was $88.47 at 10:55 AM ET.
Fundamentals show the company has a market cap of $2.9 billion and remains unprofitable with a trailing twelve-month EPS of -1.18. Revenue grew 21.6% over the same period, though the net margin stands at -4.5%. The stock has a beta of 1.47 and a 52-week range of $82.85 to $192.47. Recent insider activity includes one sale totaling $94,000 by CFO Wilson Daniel G. on September 2, 2026, with no buys recorded in the last 90 days.
What To Watch
Investors will monitor the execution of the new share repurchase program and any further analyst adjustments following the recent price target revisions.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Stocks to watch on Wednesday after hours: EZPW, IRTC, EGP
EZCORP gains 11% on a fiscal Q4 earnings beat from core pawn revenue; iRhythm approves a $200M buyback, while EastGroup says Q4 is tracking to expectations.
iRhythm Holdings authorizes $200M share repurchase program
iRhythm Holdings approves a $200 million share repurchase program and expects to use existing cash and cash equivalents plus operating cash flows.
2d agoGlobeNewswireBULLISH 71General
iRhythm Announces Approval of $200 Million Share Repurchase Program
SAN FRANCISCO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November...
2d agoBusiness InsiderBULLISH 71General
iRhythm Announces Approval of $200 Million Share Repurchase Program
SAN FRANCISCO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November...
2d agoThe FlyBEARISH 34Analyst
iRhythm price target lowered to $120 from $160 at Stephens
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →